Abstract
Background
Heterotopic ossification (HO) is a recognized postsurgical complication after total hip arthroplasty. Brooker et al. [6] established a grading system to define the degree of HO. The results of several studies have shown that non-steroidal anti-inflammatory drugs (NSAID) and radiation therapy reliably reduce the occurrence of severe HO. The exact cause and mechanism of bone formation are not known. The efficacy of indomethacin versus meloxicam for the prevention of heterotopic periarticular ossification and clinical NSAID side-effects after primary, cementless total hip arthroplasty was evaluated.
Methods
Probands underwent cementless total hip replacements at the Orthopaedic Department, Hospital Wiener Neustadt, from January 1997 to January 1998, did not take NSAID up to 4 weeks preoperatively and had no NSAID contraindications. Patients were separated into two groups by different hospitalisation floors. All patients selected for this study suffered from primary or secondary coxarthrosis. Data were collected as a prospective, randomised, parallel group study. Patients were given 50 mg indomethacin 2 times daily (n=58) vs 7.5 mg meloxicam (n=58) in a 12-day treatment course.
Results
A two-sided Cochran-Armitage trend test showed no statistically significant difference (p<0.05) for one of the drugs regarding influence on ectopic bone formation according to the grading system of Brooker et al.
Conclusion
Our study demonstrates that there is no statistically significant trend that indomethacin or meloxicam protects a hip arthroplasty better from heterotopic bone formation. We prefer indomethacin therapy because it is almost half the price of meloxicam therapy, and we recommend indomethacin in a 12-day treatment course given 50 mg 2 times daily as an effective, inexpensive and easily administered HO prophylaxis.
Similar content being viewed by others
References
Arcq M (1973) Die paraartikulären Ossifikationen—eine Komplikation der Totalendoprothese des Hüftgelenkes. Arch Orthop 77:108–131
Barner A (1996) Review of clinical trials and benefit/risk ratio of meloxicam. Scand J Rheumatol 25 [Suppl 102]:29–37
Bengt IE et al (1991) Prevention of deep vein thrombosis and pulmonary embolism after total hip replacement. J Bone Joint Surg Am 73:484–493
Braun K (1999) Präopertive Radiatio zur Prophylaxe heterotoper Ossifikationen nach endoprothetischem Hüftgelenkersatz. Z Orthop 137:22–23
Bremen-Kühne R v et al (1997) Indomethacin—Kurzzeittherapie vs Einzeitige low-dose-radiatio zur Prophylaxe perirtkulärer Ossifikationen (PAO) nach HTEP. Z Orthop 135:422–429
Brooker AF et al (1973) Ectopic ossification following total hip replacement. J Bone Joint Surg Am 55:1629–1632
Brückl R, Frey M (1997) Prophylaxe paraartikulärer Ossifikation durch Strahlentherapie nach zementloser Hüft-TEP-Implantation. Z Orthop 135:430–433
DeLee J, Ferrari A, Charnley J (1976) Ectopic bone formation following low friction arthroplasty of the hip. Clin Orthop 121:53–59
Dequecker J et al (1998) Improvement in gastrointestinal tolerability the selective cyclooxigenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the safety and efficacy large-scale evaluation of COX-inhibiting therapies (SELECT) trial in osteoarthritis. Br J Rheumatol 37:946–951
Dorn U et al (1998) Indomethacin for prevention of heterotopic ossification after hip arthroplasty. Acta Orthop Scand 69:107–110
Drees P (1999) Das Risiko periartikulärer Ossifikationen beim Hüftgelenkersatz. Z Orthop 137:16–17
Emery P (1996) Clinical implications of selective cyclooxygenase-2 inhibition. Scand J Rheumatol 25 [Suppl 102]:23–28
Fröhling MA (1998) Periartikuläre heterotope Ossifikationen nach Hüft-TEP—Ein Impingement des Hüftgelenkes. Z Orthop 136:A54
Gebuhr P et al (1997) Naproxen given to prevent heterotopic ossification does not increase prosthetic loosening. Orthopaedics 5:21–23
Gierse H et al (1997) Zur Prophylaxe von periartikulären Vernöcherungen—mit Ergebnissen einer randomisierten, doppelblinden Studie zum Vergleich von Acemetacin versus Indometacin. Z Orthop 135:417–421
Goldmann AR et al (1993) Strahlentherapie zur Prophylaxe von periartkulären, heterotopen Ossifikationen nach Implantation von HTEP. Z Orthop 131:151–155
Hawkey C et al (1998) Gastrointestinal tolerability of the COX-2 inhibitor, meloxicam, in osteoarthritis patients: the meloxicam large scale international study safety asesment (MELISSA). Br J Rhreumatol 37:937–945
Heyd R et al (1995) Die postoperative, konventionelle fraktionierte Strahlentherapie zur Prävention heterotoper Ossifikationen nach TEP des Hüftgelenks. Röntgenpraxis 48:233–237
Jockheck M et al (1998) Prevention of periarticular heterotopic ossification after endoprosthetic hip joint replacement by means of diclofenac. Arch Orthop Trauma Surg 117:337–340
Kienapfel H et al (1999) Prevention of heterotopic bone formation after total hip arthroplasty: a prospective randomised study comparing postoperative radiation therapy with indomethacin medication. Arch Orthop Trauma Surg 119:296–302
Knelles D et al (1997) Prevention of heterotopic ossification after total hip replacement. J Bone Joint Surg Br 79:596–602
Koorevaar CT et al (1999) No effective prophylaxis of heterotopic ossification with short-term ibuprofen. Arch Orthop Trauma Surg 119:183–185
Lockie LM (1986) Tolerability and efficacy of long-term daily administration of indomethacin for moderate to severe chronic arthritic disorders. Clin Ther 8:398–405
Moore K D et al (1998) Indomethacin versus radiation therapy for prophylaxis against heterotopic ossification in acetabular fractures. J Bone Joint Surg Br 80:259–263
Nilsson OS (1998) Heterotopic ossification—editorial. Acta Orthop Scand 69:103–106
Noble S, Balfour JA (1996) Meloxicam. Drugs 51:424–432
Patrignani P et al (1997) Differential inhibition of human protaglandin endoperoxide synthase-1 and -2 by nonsteroidal antiinflammatory drugs. J Physiol Pharmacol 48:623–631
Peterson P-E et al (1998) Preventive effects of ibuprofen on periarticular heterotopic ossification after total hip arthroplasty. Acta Orthop Scand 69:111–115
Quack G et al (1998) Prä– versus postoperative Radiatio zur Prophylaxe von postoperativen Ossifikationen nach TEP. Z Orthop 136
Ritter MA, Sieber JM (1985) Prophylactic indomethacin for prevention of heterotopic bone formation following total hip arthroplasty. Clin Orthop 196:217–225
Schmidt SA et al (1988) The use of indomethacin to prevent the formation of heterotopic bone after total hip replacement. J Bone Joint Surg Am 70:834–838
Sell S, Schleh T (1999) C-reactive protein as an early indicator of the formation of heterotopic ossifications after total hip replacement. Arch Orthop Trauma Surg 119:205–207
Van Leeuwen WM et al (1998) Preoperative irradiation for prophylaxis of ectopic ossification after hip arthroplasty. Acta Orthop Scand 69:116–118
Vane JR, Botting RM (1996) Mechanism of action of antiinflammatory drugs. Scand J Rheumatol 25 [Suppl 102]:9–21
Trnka H-J et al (1999) Stable bony integration with and without short term indomethacin prophylaxis. Arch Orthop Trauma Surg 119:456–460
Acknowledgements
Thanks to Mag. Thomas Lang, statistical consultant, Institute of Medical Statistics, University of Vienna, Schwarzspanierstrasse 17, 1090 Vienna, Austria. No grants were received for this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Legenstein, R., Bösch, P. & Ungersböck, A. Indomethacin versus meloxicam for prevention of heterotopic ossification after total hip arthroplasty. Arch Orthop Trauma Surg 123, 91–94 (2003). https://doi.org/10.1007/s00402-003-0487-y
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00402-003-0487-y